Methods FDG-PET imaging was performed in two women with augmentation
mammoplasties and small palpable breast abnormalities. Mammograms with and without …

Objective: To assess the diagnostic efficiency of positron emission tomography with 18‐
fluorine fluorodeoxyglucose in detecting breast cancer in augmented breasts. Design …

The purpose of the study was to demonstrate the feasibility of a hybrid functional/anatomic
breast imaging platform with biopsy capability for facilitating lesion detection and diagnosis …

Present limitations of available procedures for the diagnosis of breast cancer have
stimulated the development of new methods based on Positron Emission Tomography …

Purpose To evaluate the clinical feasibility of high-resolution dedicated breast positron
emission tomography (dbPET) with real low-dose 18F-2-fluorodeoxy-d-glucose (18F-FDG) …

Background FDG PET has not yet found a role in the clinical evaluation of the tumor extent of
breast cancer. FDG PET has been reported to be useful for evaluating the prognoses of …

The exact roles of PET in the imaging management of patients with known or suspected
breast cancer are still in evolution. For assessing primary lesions, it is sometimes possible …

Primary breast cancer imaging can be done by various means. Mammography is the most
widely used technique because of its excellent diagnostic performance, patient compliance …

OBJECTIVE. The purposes of this study were to evaluate the diagnostic performance of
dedicated breast PET (dbPET) in cases of unexpected uptake and to define parameters …

Background Positron emission tomography (PET) imaging using [18 F] fluorodeoxyglucose
(18 F-FDG) is recognized to have a major role in oncological imaging. Over recent years …